Search research articles
Contact Us
Filters
Showing results (41-50 of 44) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 44 results.
Current Genetics
|
March 1, 1990
Cloning, characterization, and expression of two alpha-amylase genes from Aspergillus niger var. awamori
D R Korman, F T Bayliss, C C Barnett, et al.
Chemical Communications (Cambridge, England)
|
August 3, 2005
Superparamagnetic gadonanotubes are high-performance MRI contrast agents
B Sitharaman, K R Kissell, K B Hartman, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 17, 2001
The identification and characterization of hydrazinyl urea-based antibacterial agents through combinatorial chemistry
L J Wilson, T W Morris, Q Wu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 5, 2002
Discriminators between hantavirus-infected and -uninfected persons enrolled in a trial of intravenous ribavirin for presumptive hantavirus pulmonary syndrome
L E Chapman, B A Ellis, F T Koster, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 44) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 44 results.
Current Genetics
|
March 1, 1990
Cloning, characterization, and expression of two alpha-amylase genes from Aspergillus niger var. awamori
D R Korman, F T Bayliss, C C Barnett, et al.
Chemical Communications (Cambridge, England)
|
August 3, 2005
Superparamagnetic gadonanotubes are high-performance MRI contrast agents
B Sitharaman, K R Kissell, K B Hartman, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 17, 2001
The identification and characterization of hydrazinyl urea-based antibacterial agents through combinatorial chemistry
L J Wilson, T W Morris, Q Wu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 5, 2002
Discriminators between hantavirus-infected and -uninfected persons enrolled in a trial of intravenous ribavirin for presumptive hantavirus pulmonary syndrome
L E Chapman, B A Ellis, F T Koster, et al.
Page
of 5